Optipharm.CO.,LTD (KOSDAQ: 153710)

Optipharm.CO.,LTD Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	12,873	2,254	5,573	8,187	15,725	20,192
Short-Term Investments	2,558	13,396	11,048	13,919	6,444	5,320
Cash & Short-Term Investments	15,431	15,651	16,621	22,106	22,169	25,512
Cash Growth	-5.80%	-5.84%	-24.81%	-0.28%	-13.11%	-2.94%
Accounts Receivable	1,192	1,369	1,124	1,001	863.24	1,104
Other Receivables	1,138	268.86	972.95	173.3	172.83	64.44
Receivables	2,511	1,783	2,231	1,314	1,235	1,168
Inventory	1,566	1,320	1,099	1,056	716.88	673.79
Prepaid Expenses	445.17	327.28	316.77	497.53	981.89	89.61
Other Current Assets	1,282	1,395	1,279	893.95	573.7	588.04
Total Current Assets	21,235	20,476	21,548	25,867	25,676	28,032
Property, Plant & Equipment	18,265	18,325	17,717	13,613	13,347	13,177
Long-Term Investments	-	0	985.74	986.09	986.39	66.12
Other Intangible Assets	290.92	281.51	258.4	263.82	272.36	245.08
Other Long-Term Assets	630.37	193.34	673.72	438.74	1,040	199.94
Total Assets	40,422	39,275	41,182	41,168	41,321	41,719
Accounts Payable	539.1	581.26	503.35	575.04	383.31	302.35
Accrued Expenses	418.23	437.63	101.92	76.1	68.29	63.82
Short-Term Debt	10,930	9,610	7,470	5,830	4,290	3,350
Current Portion of Leases	149.61	148.32	90.25	102.31	10.88	32.52
Other Current Liabilities	1,075	823.69	1,098	1,267	771.7	619.18
Total Current Liabilities	13,112	11,601	9,264	7,851	5,524	4,368
Long-Term Leases	213.41	287.95	164.08	47.15	179.84	175.28
Long-Term Unearned Revenue	1,764	887.03	1,146	324.51	225.72	23.19
Other Long-Term Liabilities	44.72	41.08	38.74	37.91	31.38	24.45
Total Liabilities	16,643	14,131	12,171	10,213	7,541	6,110
Common Stock	7,335	7,335	7,335	7,295	7,237	7,189
Additional Paid-In Capital	44,017	41,982	41,982	41,710	41,211	40,879
Retained Earnings	-26,900	-25,299	-22,404	-20,243	-16,990	-14,757
Comprensive Income & Other	-673.22	1,127	2,098	2,193	2,321	2,299
Shareholders' Equity	23,778	25,144	29,011	30,955	33,780	35,609
Total Liabilities & Equity	40,422	39,275	41,182	41,168	41,321	41,719
Total Debt	11,293	10,046	7,724	5,979	4,481	3,558
Net Cash (Debt)	4,138	5,605	8,897	16,126	17,688	21,954
Net Cash Growth	-34.81%	-37.01%	-44.83%	-8.83%	-19.43%	0.36%
Net Cash Per Share	282.10	382.05	609.19	1110.10	1225.67	1541.06
Filing Date Shares Outstanding	14.67	14.67	14.67	14.59	14.47	14.38
Total Common Shares Outstanding	14.67	14.67	14.67	14.59	14.47	14.38
Working Capital	8,123	8,875	12,284	18,016	20,151	23,664
Book Value Per Share	1620.88	1714.00	1977.60	2121.75	2333.75	2476.67
Tangible Book Value	23,487	24,863	28,753	30,691	33,507	35,364
Tangible Book Value Per Share	1601.05	1694.81	1959.99	2103.67	2314.93	2459.63
Land	3,583	3,583	3,583	3,583	3,583	3,583
Buildings	14,380	14,380	10,936	10,403	10,392	10,392
Machinery	8,624	8,220	6,909	5,776	5,224	4,377
Construction In Progress	231.47	-	3,128	573.74	12.4	-

Source: S&P Capital IQ. Standard template. Financial Sources.